共 137 条
- [1] Soumerai SB(1988)Factors influencing prescribing Aust J Hosp Pharm 18 9-16
- [2] Lamas GA(1992)Do the results of randomized trials of cardiovascular drugs influence medical practice? N Engl J Med 327 241-7
- [3] Pfeffer MA(1990)The cholesterol facts—a summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease Circulation 81 1721-33
- [4] Hamm P(1996)Cholesterol reduction: weighing the benefits and risks Ann Intern Med 124 914-8
- [5] La Rosa JC(1996)Lipid lowering therapy for patients with or at risk of coronary artery disease Curr Opin Cardiol 11 418-27
- [6] Hunninghake D(1997)Cholesterol management in theory and practice Circulation 96 4424-30
- [7] Bush D(1992)HMG CoA reductase inhibitors: a look back and a look ahead Can J Cardiol 8 843-88
- [8] Gaziano JM(1993)Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II) JAMA 269 3015-23
- [9] Hebert PR(1994)Randomized trial of cholesterol lowering in 4444 with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1383-9
- [10] Hennekens CH(1994)Mortality risk and patterns of practice in 2,070 patients with acute myocardial infarction, 1987–92 Chest 105 1687-92